Do analysts prefer TACO or ACH?

Accendra Health has a consensus target price of $1.50, indicating a potential upside of 58.66%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Which has better valuation and earnings, TACO or ACH?

Berto Acquisition has higher earnings, but lower revenue than Accendra Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Accendra Health $2.73B 0.03 -$1.10B -$3.91 N/A

Does the media favor TACO or ACH?

In the previous week, Accendra Health had 7 more articles in the media than Berto Acquisition. MarketBeat recorded 11 mentions for Accendra Health and 4 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 0.99 beat Accendra Health's score of -0.15 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accendra Health 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ACH or SBC?

In the previous week, SBC Medical Group had 3 more articles in the media than Accendra Health. MarketBeat recorded 14 mentions for SBC Medical Group and 11 mentions for Accendra Health. SBC Medical Group's average media sentiment score of 0.09 beat Accendra Health's score of -0.15 indicating that SBC Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SBC Medical Group 0 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is BDSX or ACH more profitable?

Accendra Health has a net margin of -11.41% compared to Biodesix's net margin of -26.97%. Accendra Health's return on equity of -4.02% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -26.97% -788.19% -30.33% Accendra Health -11.41% -4.02% 0.70%

Does the media favor BDSX or ACH?

In the previous week, Biodesix had 10 more articles in the media than Accendra Health. MarketBeat recorded 21 mentions for Biodesix and 11 mentions for Accendra Health. Biodesix's average media sentiment score of 1.23 beat Accendra Health's score of -0.15 indicating that Biodesix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 11 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Accendra Health 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ACH or INFU?

In the previous week, Accendra Health had 9 more articles in the media than InfuSystem. MarketBeat recorded 11 mentions for Accendra Health and 2 mentions for InfuSystem. InfuSystem's average media sentiment score of 0.00 beat Accendra Health's score of -0.15 indicating that InfuSystem is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral InfuSystem 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is LFMD or ACH more profitable?

LifeMD has a net margin of 0.10% compared to Accendra Health's net margin of -11.41%. Accendra Health's return on equity of -4.02% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 0.10% -168.23% -31.27% Accendra Health -11.41% -4.02% 0.70%

Does the media favor LFMD or ACH?

In the previous week, LifeMD had 3 more articles in the media than Accendra Health. MarketBeat recorded 14 mentions for LifeMD and 11 mentions for Accendra Health. LifeMD's average media sentiment score of 0.32 beat Accendra Health's score of -0.15 indicating that LifeMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Accendra Health 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Accendra Health (ACH) Competitors

$0.95 -0.15 (-14.05%)

As of 08/14/2026 03:58 PM Eastern

Compare

ACH vs. TACO, SBC, BDSX, INFU, and LFMD

Should you buy Accendra Health stock or one of its competitors? Accendra Health's main competitors and comparable companies include Berto Acquisition (TACO), SBC Medical Group (SBC), Biodesix (BDSX), InfuSystem (INFU), and LifeMD (LFMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Accendra Health compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

Berto Acquisition has a net margin of 0.00% compared to Accendra Health's net margin of -11.41%. Berto Acquisition's return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Accendra Health	-11.41%	-4.02%	0.70%

Accendra Health has a consensus target price of $1.50, indicating a potential upside of 58.66%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

In the previous week, Accendra Health had 7 more articles in the media than Berto Acquisition. MarketBeat recorded 11 mentions for Accendra Health and 4 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 0.99 beat Accendra Health's score of -0.15 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accendra Health	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Berto Acquisition has a beta of 0.07, meaning that its share price is 93% less volatile than the broader market. Comparatively, Accendra Health has a beta of 1.58, meaning that its share price is 58% more volatile than the broader market.

Berto Acquisition has higher earnings, but lower revenue than Accendra Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A

Summary

Accendra Health beats Berto Acquisition on 6 of the 9 factors compared between the two stocks.

How does Accendra Health compare to SBC Medical Group?

Accendra Health (NYSE:ACH) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Accendra Health currently has a consensus target price of $1.50, suggesting a potential upside of 58.66%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 132.24%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Accendra Health has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

SBC Medical Group has lower revenue, but higher earnings than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A
SBC Medical Group	$173.61M	2.16	$50.99M	$0.47	7.79

SBC Medical Group has a net margin of 27.99% compared to Accendra Health's net margin of -11.41%. SBC Medical Group's return on equity of 18.81% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-11.41%	-4.02%	0.70%
SBC Medical Group	27.99%	18.81%	13.49%

In the previous week, SBC Medical Group had 3 more articles in the media than Accendra Health. MarketBeat recorded 14 mentions for SBC Medical Group and 11 mentions for Accendra Health. SBC Medical Group's average media sentiment score of 0.09 beat Accendra Health's score of -0.15 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
SBC Medical Group	0 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

60.8% of SBC Medical Group shares are held by institutional investors. 2.3% of Accendra Health shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

SBC Medical Group beats Accendra Health on 14 of the 16 factors compared between the two stocks.

How does Accendra Health compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

Biodesix presently has a consensus target price of $31.33, suggesting a potential upside of 30.56%. Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 58.66%. Given Accendra Health's higher possible upside, analysts clearly believe Accendra Health is more favorable than Biodesix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Biodesix has higher earnings, but lower revenue than Accendra Health. Biodesix is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	2.86	-$35.26M	-$3.17	N/A
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A

In the previous week, Biodesix had 10 more articles in the media than Accendra Health. MarketBeat recorded 21 mentions for Biodesix and 11 mentions for Accendra Health. Biodesix's average media sentiment score of 1.23 beat Accendra Health's score of -0.15 indicating that Biodesix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	11 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Accendra Health	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Accendra Health has a net margin of -11.41% compared to Biodesix's net margin of -26.97%. Accendra Health's return on equity of -4.02% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-26.97%	-788.19%	-30.33%
Accendra Health	-11.41%	-4.02%	0.70%

Biodesix has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, Accendra Health has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market.

21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by company insiders. Comparatively, 2.3% of Accendra Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Biodesix beats Accendra Health on 10 of the 17 factors compared between the two stocks.

How does Accendra Health compare to InfuSystem?

Accendra Health (NYSE:ACH) and InfuSystem (NYSE:INFU) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

71.1% of InfuSystem shares are held by institutional investors. 2.3% of Accendra Health shares are held by company insiders. Comparatively, 10.8% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Accendra Health currently has a consensus price target of $1.50, suggesting a potential upside of 58.66%. InfuSystem has a consensus price target of $16.67, suggesting a potential upside of 35.83%. Given Accendra Health's higher possible upside, equities research analysts plainly believe Accendra Health is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Accendra Health has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, InfuSystem has a beta of 1.42, meaning that its stock price is 42% more volatile than the broader market.

InfuSystem has lower revenue, but higher earnings than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A
InfuSystem	$143.34M	1.73	$870K	$0.41	29.93

In the previous week, Accendra Health had 9 more articles in the media than InfuSystem. MarketBeat recorded 11 mentions for Accendra Health and 2 mentions for InfuSystem. InfuSystem's average media sentiment score of 0.00 beat Accendra Health's score of -0.15 indicating that InfuSystem is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
InfuSystem	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InfuSystem has a net margin of 1.12% compared to Accendra Health's net margin of -11.41%. InfuSystem's return on equity of 2.78% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-11.41%	-4.02%	0.70%
InfuSystem	1.12%	2.78%	1.41%

Summary

InfuSystem beats Accendra Health on 12 of the 16 factors compared between the two stocks.

How does Accendra Health compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

LifeMD has a beta of 2.02, suggesting that its stock price is 102% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market.

In the previous week, LifeMD had 3 more articles in the media than Accendra Health. MarketBeat recorded 14 mentions for LifeMD and 11 mentions for Accendra Health. LifeMD's average media sentiment score of 0.32 beat Accendra Health's score of -0.15 indicating that LifeMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeMD	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Accendra Health	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeMD has a net margin of 0.10% compared to Accendra Health's net margin of -11.41%. Accendra Health's return on equity of -4.02% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	0.10%	-168.23%	-31.27%
Accendra Health	-11.41%	-4.02%	0.70%

LifeMD has higher earnings, but lower revenue than Accendra Health. LifeMD is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	0.86	$14.35M	-$0.05	N/A
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A

LifeMD currently has a consensus target price of $7.57, indicating a potential upside of 119.46%. Accendra Health has a consensus target price of $1.50, indicating a potential upside of 58.66%. Given LifeMD's stronger consensus rating and higher possible upside, equities analysts clearly believe LifeMD is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	2 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.60
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by insiders. Comparatively, 2.3% of Accendra Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

LifeMD beats Accendra Health on 12 of the 16 factors compared between the two stocks.

Get Accendra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACH vs. The Competition

Export

Metric	Accendra Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$73.13M	$9.87B	$7.03B	$24.33B
Dividend Yield	N/A	2.54%	2.57%	3.68%
P/E Ratio	-0.24	35.17	271.54	30.85
Price / Sales	0.03	4.87	673.88	17.93
Price / Cash	0.25	124.24	75.70	32.61
Price / Book	-0.13	3.94	12.92	6.82
Net Income	-$1.10B	$309.96M	$3.45B	$1.06B
7 Day Performance	-67.95%	0.09%	1.16%	0.55%
1 Month Performance	-74.99%	-0.34%	2.17%	2.70%
1 Year Performance	N/A	19.48%	62.38%	19.14%

Accendra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACH Accendra Health	1.9271 of 5 stars	$0.95 -14.1%	$1.50 +58.7%	N/A	$73.13M	$2.73B	N/A	6,500	Earnings Report Analyst Downgrade High Trading Volume
TACO Berto Acquisition	1.5643 of 5 stars	$10.46 +0.0%	N/A	+0.9%	$341.04M	N/A	N/A	7,892	News Coverage Positive News Earnings Report Short Interest Decrease
SBC SBC Medical Group	3.4175 of 5 stars	$3.05 -4.7%	$8.50 +178.7%	-17.9%	$312.36M	$173.61M	7.81	N/A	Trending News Earnings Report Analyst Forecast High Trading Volume
BDSX Biodesix	4.651 of 5 stars	$23.99 -1.0%	$31.33 +30.6%	+202.8%	$253.04M	$88.50M	N/A	220	News Coverage Positive News Insider Trade
INFU InfuSystem	3.2044 of 5 stars	$12.38 +1.1%	$16.67 +34.6%	+27.4%	$249.85M	$143.34M	206.37	410

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ACH) was last updated on 8/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accendra Health (ACH) Competitors

ACH vs. TACO, SBC, BDSX, INFU, and LFMD

How does Accendra Health compare to Berto Acquisition?

Summary

How does Accendra Health compare to SBC Medical Group?

Summary

How does Accendra Health compare to Biodesix?

Summary

How does Accendra Health compare to InfuSystem?

Summary

How does Accendra Health compare to LifeMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACH vs. The Competition

Accendra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Accendra Health (ACH) Competitors

ACH vs. TACO, SBC, BDSX, INFU, and LFMD

How does Accendra Health compare to Berto Acquisition?

Is TACO or ACH more profitable?

Do analysts prefer TACO or ACH?

Does the media favor TACO or ACH?

Which has more risk and volatility, TACO or ACH?

Which has better valuation and earnings, TACO or ACH?

Summary

How does Accendra Health compare to SBC Medical Group?

Do analysts prefer ACH or SBC?

Which has more volatility & risk, ACH or SBC?

Which has better earnings and valuation, ACH or SBC?

Is ACH or SBC more profitable?

Does the media refer more to ACH or SBC?

Do institutionals and insiders hold more shares of ACH or SBC?

Summary

How does Accendra Health compare to Biodesix?

Do analysts rate BDSX or ACH?

Which has better valuation & earnings, BDSX or ACH?

Does the media favor BDSX or ACH?

Is BDSX or ACH more profitable?

Which has more volatility and risk, BDSX or ACH?

Do institutionals & insiders believe in BDSX or ACH?

Summary

How does Accendra Health compare to InfuSystem?

Do institutionals and insiders hold more shares of ACH or INFU?

Do analysts recommend ACH or INFU?

Which has more volatility and risk, ACH or INFU?

Which has stronger valuation and earnings, ACH or INFU?

Does the media refer more to ACH or INFU?

Is ACH or INFU more profitable?

Summary

How does Accendra Health compare to LifeMD?

Which has more volatility & risk, LFMD or ACH?

Does the media favor LFMD or ACH?

Is LFMD or ACH more profitable?

Which has preferable valuation and earnings, LFMD or ACH?

Do analysts prefer LFMD or ACH?

Do institutionals & insiders have more ownership in LFMD or ACH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACH vs. The Competition

Accendra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools